Metropolis Healthcare

Crisil Ratings has revised its outlook on the long-term bank facilities and non-convertible debentures of Metropolis Healthcare Ltd (MHL) to 'positive' from 'stable', while reaffirming its rating at 'Crisil AA-'. The rating agency also reaffirmed its short-term bank facility rating at 'Crisil A1+', according to a note from Crisil Ratings. Crisil said the outlook revision reflects the expected improvement in organic revenue growth, profitability, and cash accruals, along with a meaningful turnaround in its recent acquisition, Core Diagnostics Pvt Ltd. Higher utilisation of the expanded laboratory network, a favourable test mix, and better profitability at Core Diagnostics are expected to support healthy operating margins over the medium term, the agency noted. According to the rating agency, MHL's revenue increased 24 per cent to Rs 1,646 crore in FY26, driven by higher patient volumes and specialised diagnostic and wellness tests under the 'TruHealth' brand. Revenue growth continu

Updated On: 23 Sep 2026 | 11:17 AM IST

Brokerages expect listed diagnostics majors to maintain volume growth through FY27, helped by stable pricing, B2C demand and operating leverage

Updated On: 13 Sep 2026 | 3:57 PM IST

Diagnostics chain plans to sweat existing lab infrastructure, expand company-owned centres from 750 to 1,000

Updated On: 02 Sep 2026 | 2:12 PM IST

Metropolis Healthcare share hit a 52-week high of ₹574.45, surging 14 per cent in trade. Thyrocare soared 12 per cent to ₹526.10, while Vijaya Diagnostic Centre gained 7 per cent to ₹1,298.45.

Updated On: 08 May 2026 | 3:28 PM IST

Investors will keep an eye on DIC India, as the company has declared a final dividend of ₹3 per share, with the record date fixed on March 16

Updated On: 13 Mar 2026 | 11:22 AM IST

In a video-interview with Sohini Das, Surendran Chemmenkotil, Managing Director of Metropolis Healthcare, speaks about the company's FY27 network expansion strategy

Updated On: 06 Feb 2026 | 12:17 AM IST

India's second-largest pathology chain reported strong year-on-year profit growth in the December quarter, supported by higher test volumes, preventive care demand and specialised diagnostics

Updated On: 04 Feb 2026 | 8:45 PM IST

Metropolis Healthcare shares rose 6 per cent it reported a 26 per cent Y-o-Y jump in its standalone revenue in the third quarter of the current financial year

Updated On: 05 Jan 2026 | 1:29 PM IST

Metropolis Healthcare has rolled out three TruHealth GLP-1 test packages for patients preparing for or undergoing obesity treatment, as diagnostics firms move to tap the fast-growing segment

Updated On: 02 Dec 2025 | 6:27 PM IST

Metropolis Healthcare posted a 13% rise in Q2FY26 net profit to ₹53 crore, driven by increased patient and test volumes, network expansion, and improved performance across regions

Updated On: 04 Nov 2025 | 10:04 PM IST

Domestic brokerage firm Nuvama analysts forecast a modest sequential slowdown but a healthy ~17 per cent year-on-year (Y-o-Y) Ebitda growth, led by hospitals and diagnostics.

Updated On: 09 Oct 2025 | 8:49 AM IST

According to the company filing, it delivered a 23 per cent year-on-year (Y-o-Y) revenue growth at the consolidated level, driven by robust momentum in preventive health check-ups

Updated On: 07 Oct 2025 | 12:55 PM IST

Metropolis added that the move is expected to enhance productivity and drive overall profitability across its network of laboratories operating in the region

Updated On: 19 Sep 2025 | 4:08 PM IST

Technical charts show that Dixon Technologies, Kirloskar Oil Engines, Metropolis Healthcare and RHI Magnesita have witnessed a 'Golden Crossover', hence are likely to see upside in the near-term.

Updated On: 13 Aug 2025 | 12:04 PM IST

'Amazon's entry is through a partnership with Orange Health. It is more of a distribution through Amazon'

Updated On: 11 Aug 2025 | 12:00 AM IST

Despite trading in overbought territory Delhivery, Metropolis Health look poised for up to 19% further gains, while Usha Martin stock could dip 9%; suggest technical charts.

Updated On: 09 Jul 2025 | 1:38 PM IST

At 6:40 AM, GIFT Nifty futures were trading 90 points higher at 24,730 level, indicating a higher start.

Updated On: 14 May 2025 | 7:35 AM IST

Metropolis Q4 profit dips due to one-off costs from acquisitions; FY25 profit rises 13.4% on demand for preventive testing and strong B2C, B2B growth

Updated On: 13 May 2025 | 8:57 PM IST

With its third acquisition in recent times, Metropolis' Ameera Shah said the firm will make another deal this financial year

Updated On: 07 Apr 2025 | 10:54 PM IST

Under the agreement, Metropolis' wholly-owned subsidiary Metropolis Histoxpert Digital Services Pvt Ltd will acquire 100 per cent ownership of DAPIC

Updated On: 07 Apr 2025 | 9:50 AM IST